Dacomitinib Hydrate and its Impurities

Dacomitinib Hydrate, sold under the brand name Vizimpro, is a medication for the treatment of non-small-cell lung carcinoma. Reference standards of Dacomitinib Hydrate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.